Eric Quéméneur

Eric Quéméneur has a diverse and extensive work experience. Eric is currently serving as the Vice President and Chief Scientific Officer at Transgene since October 2014. Prior to that, they worked at CEA - Commissariat à l'énergie atomique et aux énergies alternatives for a significant period. At CEA, they held various roles including Director of Research Programs and Industrial Partnerships - Life Sciences from September 2010 to September 2014, Director of Corporate Toxicology Program from May 2009 to April 2013, Head of Research Unit, Biochemistry & Toxicology from 2000 to 2010, Head of Laboratory, Protein Engineering Department from 1992 to 2000, and Research Scientist from January 1990 to May 1992. Before joining CEA, Eric worked at Service de Santé des Armées (SSA) as an Associate Research Fellow from January 1989 to December 1989. Eric also gained research experience as a Research Associate (PhD fellow) at Hoechst AG from September 1986 to November 1988.

Eric Quéméneur has a Doctorat degree in Biochimie from Université Claude Bernard Lyon 1, which they obtained in 1989. Prior to that, in 1988, they also completed a Doctorat degree in Pharmacie from the same university. Additionally, in 1999, they earned an HDR degree from Pierre and Marie Curie University. Eric's education history also includes studying at INSA Lyon - Institut National des Sciences Appliquées de Lyon, although specific details about their degree or field of study are not provided.